Echocardiography (Mount Kisco, N.Y.) · 2025
Segmental Strain and Strain-Rate Imaging to Assess Cardiac Function in Patients With Limb-Girdle Muscular Dystrophy R9: An Observational Study of the Norwegian LGMDR9 Cohort.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Caglayan Safak, Akay Caglayan Hatice, Jensen Synnøve M, Arntzen Kjell Arne, Rösner Assami
Аннотация
PURPOSE: Cardiomyopathy is a prevalent feature of limb-girdle muscular dystrophy R9 (LGMDR9), but its characterization remains incomplete. This study aims to assess cardiac function in patients with LGMDR9 using global and segmental myocardial function imaging.
METHODS: A total of 42 participants (aged 23-71 years) from the Norwegian LGMDR9 cohort were compared with 97 controls (aged 40-69 years) from the Tromsø Study. Conventional and speckle tracking echocardiography were performed to assess cardiac function. Statistical analyses were adjusted for age and sex.
RESULTS: Patients with LGMDR9 had significantly reduced left ventricular ejection fraction (LVEF: 52.2% vs. 57.0%, p < 0.001) and decreased absolute global longitudinal strain (GLS: 17.6% vs. 20.5%, p < 0.001). Systolic dysfunction in patients was further observed by increased end-systolic left ventricular volume and internal diameter. Diastolic dysfunction was evident with reduced early to late ventricular filling velocities and further verified by decreased longitudinal strain-rate during early diastole (SR-E) and increased longitudinal strain-rate during atrial contraction (SR-A). Importantly, segmental analysis revealed region-specific differences in strain and strain-rate; mid and apical segments had decreased absolute strain, while basal segments remained largely unaffected. Notably, patients with normal LVEF also displayed decreased GLS (18.7% vs. 20.6%, p < 0.001) and regional and segmental alterations in strain and strain-rate.
CONCLUSION: We demonstrate that patients with LGMDR9 exhibit both systolic and diastolic dysfunction, primarily affecting the mid and apical myocardial segments. Strain and strain-rate imaging may serve as sensitive tools for early detection of myocardial dysfunction, and support clinical management and interventional studies in LGMDR9.
METHODS: A total of 42 participants (aged 23-71 years) from the Norwegian LGMDR9 cohort were compared with 97 controls (aged 40-69 years) from the Tromsø Study. Conventional and speckle tracking echocardiography were performed to assess cardiac function. Statistical analyses were adjusted for age and sex.
RESULTS: Patients with LGMDR9 had significantly reduced left ventricular ejection fraction (LVEF: 52.2% vs. 57.0%, p < 0.001) and decreased absolute global longitudinal strain (GLS: 17.6% vs. 20.5%, p < 0.001). Systolic dysfunction in patients was further observed by increased end-systolic left ventricular volume and internal diameter. Diastolic dysfunction was evident with reduced early to late ventricular filling velocities and further verified by decreased longitudinal strain-rate during early diastole (SR-E) and increased longitudinal strain-rate during atrial contraction (SR-A). Importantly, segmental analysis revealed region-specific differences in strain and strain-rate; mid and apical segments had decreased absolute strain, while basal segments remained largely unaffected. Notably, patients with normal LVEF also displayed decreased GLS (18.7% vs. 20.6%, p < 0.001) and regional and segmental alterations in strain and strain-rate.
CONCLUSION: We demonstrate that patients with LGMDR9 exhibit both systolic and diastolic dysfunction, primarily affecting the mid and apical myocardial segments. Strain and strain-rate imaging may serve as sensitive tools for early detection of myocardial dysfunction, and support clinical management and interventional studies in LGMDR9.